| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND K-1-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 2,15% | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND K-1-DIST | DEUDA PRIVADA EMERGENTES HRD CCY | 0,97% | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND P-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 1,65% | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND Q-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 2,06% | · | · | · |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) QL-ACC | RVI BIOTECNOLOGÍA | 33,18% | 58,00% | 46,13% | · |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR HEDGED) P-ACC | RVI CHINA | -20,40% | 1,62% | -37,27% | · |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR HEDGED) Q-ACC | RVI CHINA | -19,48% | 4,93% | -34,01% | · |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR) I-A1-ACC | RVI CHINA | -14,75% | 5,14% | -22,88% | · |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR) P-ACC | RVI CHINA | -15,74% | 1,48% | -27,29% | · |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR) Q-ACC | RVI CHINA | -14,78% | 4,77% | -23,52% | · |
